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BACKGROUND: The impact of comprehensive gene screening for Japanese patients with hypertrophic 
cardiomyopathy (HCM) on prognosis is unresolved.   
 
METHODS: Seventy consecutive patients (44 male, 58.3 ± 13.9 y.o.) with clinically diagnosed HCM were 
enrolled. Genetic analysis with using direct sequence of  five HCM-susceptibility myofilament genes that 
encode sarcomeric proteins (MYH7, MYBPC3, TNNI3, TNNT2 and TPMI1) was performed.   
 
RESULT: The gene mutations were observed in 35 patients.  The relationship between positive gene 
mutation and clinical outcome was evaluated. During 7.8 ± 1.9 years, 18 cardiovascular events including 
five HCM-related deaths were observed.  Survival and event- free rate in patients with positive mutation 
were worse than those in patients with negative mutation (Figure).  
 
CONCLUSION: Comprehensive gene screening is useful in the prediction of prognosis in Japanese 
patients with HCM 
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